Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maspex (Grupa Maspex) is the largest private food and beverage company in Poland and one of the largest in Central and Eastern Europe. While primarily known for its extensive portfolio of juices, nectars, pasta, and alcoholic beverages, the company also operates a significant pharmaceutical and consumer health division through its subsidiary, Polski Lek. Polski Lek specializes in developing and manufacturing dietary supplements, medical devices, and OTC pharmaceutical preparations, particularly targeting vulnerable groups such as pregnant women, infants, and children. Its notable health brands include Plusssz (vitamins), Sonoxen (sleep aid), Pedicetamol (fever/pain reducer), and ENTitis (ENT health). Maspex operates 18 modern production facilities across Europe and distributes its products to over 80 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maspex.